Nancy Ghattas

Nancy Ghattas is an experienced professional in the pharmaceutical industry, currently serving as the VP of US Commercial Oncology for the DNA Damage Response Franchise at AstraZeneca, focusing on GYN, GU, and Breast cancer. Prior to this role, Nancy held the position of Vice President for Global Commercial Respiratory Biologics at Allergan and served as Associate Vice President Country Manager for the UK and Ireland. Nancy's extensive background also includes roles at Merck as Executive Director for the Global Brand Leader of the HIV Franchise, Executive Director of Strategic Planning Operations, and Chief of Staff for the GHH President, as well as Business Unit Director for Cardiometabolic. Nancy Ghattas holds a Bachelor’s degree in Pharmacy and Pharmaceutical Sciences from Cairo University, completed between 1998 and 2003.